Shares of pharmacy benefit managers 
Bourla’s remarks, following comments from Trump Monday and continued criticism from members of Congress, suggest pharmacy benefit managers are unlikely to see relief from political scrutiny during a second Trump term.
“The president has very strong views” on PBMs, Bourla 
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.


